Join this live webinar to learn more.
Patient-derived organoids are emerging as powerful tools for translational research, offering physiologically relevant models that better reflect human biology than traditional in vitro systems. Their ability to preserve key characteristics of patient tissues presents new opportunities for disease modeling, target validation, biomarker discovery, and therapeutic evaluation. This webinar explores the growing role of organoid technologies in drug development and discuss how patient-derived organoid platforms can support more informed decision-making throughout the process. Drawing on recent experience and case examples, the session will highlight practical applications, current challenges, and future opportunities for integrating organoids into translational research.
Offered Free by: Samsung Biologics
See All Resources from: Samsung Biologics
